The store will not work correctly when cookies are disabled.
3-((6-chlorothiazolo[5,4-b]pyridin-2-yl)methoxy)-2,6-difluorobenzenesulfonamide
ID: ALA4070966
PubChem CID: 74762762
Max Phase: Preclinical
Molecular Formula: C13H8ClF2N3O3S2
Molecular Weight: 391.81
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: NS(=O)(=O)c1c(F)ccc(OCc2nc3cc(Cl)cnc3s2)c1F
Standard InChI: InChI=1S/C13H8ClF2N3O3S2/c14-6-3-8-13(18-4-6)23-10(19-8)5-22-9-2-1-7(15)12(11(9)16)24(17,20)21/h1-4H,5H2,(H2,17,20,21)
Standard InChI Key: XMKAGILFEZNQHU-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
9.1336 -4.8454 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4278 -5.2581 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
9.1381 -5.6629 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0746 -2.7281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0734 -3.5476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7815 -3.9566 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.7797 -2.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4883 -2.7245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4886 -3.5476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2715 -3.8018 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.7552 -3.1357 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2711 -2.4699 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.3668 -2.3196 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5.5724 -3.1354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9813 -3.8429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7985 -3.8427 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2046 -4.5528 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0210 -4.5529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4302 -3.8445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0169 -3.1346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2018 -3.1380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7945 -5.2597 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
9.2473 -3.8431 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
8.0208 -5.9683 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
4 13 1 0
11 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
17 22 1 0
19 23 1 0
18 2 1 0
2 24 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 391.81 | Molecular Weight (Monoisotopic): 390.9664 | AlogP: 2.85 | #Rotatable Bonds: 4 |
Polar Surface Area: 95.17 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.20 | CX Basic pKa: ┄ | CX LogP: 2.40 | CX LogD: 2.06 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.74 | Np Likeness Score: -2.12 |
References
1. Hu Z, Zhang S, Zhou W, Ma X, Xiang G.. (2017) Synthesis and antibacterial activity of 3-benzylamide derivatives as FtsZ inhibitors., 27 (8): [PMID:28285910] [10.1016/j.bmcl.2017.02.032] |